PlumX Metrics
Embed PlumX Metrics

Botulinum Toxin in Facial Rejuvenation: An Update

Obstetrics and Gynecology Clinics of North America, ISSN: 0889-8545, Vol: 37, Issue: 4, Page: 571-582
2010
  • 7
    Citations
  • 0
    Usage
  • 58
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    7
    • Citation Indexes
      7
  • Captures
    58

Review Description

Since its initial approval by the US Food and Drug Administration (FDA) 20 years ago for the treatment of strabismus, hemifacial spasm, and blepharospasm in adults, botulinum toxin (BTX) has become one of the most frequently requested products in cosmetic rejuvenation around the world. After years of clinical success and consistent safety in the upper face, the use of BTX has expanded and evolved to include increasingly complicated indications. In the hands of adept injectors, the focus has shifted from the treatment of individual dynamic rhytides to shaping, contouring, and sculpting, alone or in combination with other cosmetic procedures, to enhance the aesthetic appearance of the face. Although recent reports have questioned the safety of BTX, 25 years of therapeutic and over 20 years of cosmetic use has demonstrated an impressive record of safety and efficacy when used appropriately by experienced injectors. © 2010 Elsevier Inc.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know